Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Grossman

Showing results (421-430 of 794) with videos related to

Pageof 80
Sort By:
Clinical Endocrinology|May 30, 2012
Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomasCristina Capatina, Constantinos Christodoulides, Alberto Fernandez, et al.
Hormone Research|March 4, 2006
The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndromeR Dias, H L Storr, L A Perry, et al.
Archives of Endocrinology and Metabolism|April 7, 2026
A novel activating somatic mutation in EPAS1, coding for HIF-2α, in a patient with a paraganglioma and sickle cell diseaseKalyan Mansukhbhai Shekhda, Rishi Iyer, Mercedes Robledo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapyA Pollack, G K Zagars, C J Cole, et al.
Clinical Genetics|August 23, 2006
E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancerJ Lin, C P Dinney, H B Grossman, et al.
Radiology|April 6, 1999
Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modelingY Sugawara, K R Zasadny, H B Grossman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Linear growth and final height after treatment for Cushing's disease in childhoodM C Lebrethon, A B Grossman, F Afshar, et al.
The American Journal of Psychiatry|October 1, 1983
Different definitions of alcoholism, II: A pilot study of 10 definitions in a treatment settingJ H Boyd, K Derr, B Grossman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2009
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotidePhillip Kelly, Kathy T Maher, Shern L Chew, et al.
Folia Histochemica Et Cytobiologica|January 1, 1995
Non-isotopic procedure with silver staining of polyacrylamide gels in detection of genomic abnormalities in tumors using microsatellitesJ Podolski, P Hadaczek, Z Gibas, et al.
Pageof 80

Showing results (421-430 of 794) with videos related to

Sort By:
Pageof 80
Clinical Endocrinology|May 30, 2012
Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomasCristina Capatina, Constantinos Christodoulides, Alberto Fernandez, et al.
Hormone Research|March 4, 2006
The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndromeR Dias, H L Storr, L A Perry, et al.
Archives of Endocrinology and Metabolism|April 7, 2026
A novel activating somatic mutation in EPAS1, coding for HIF-2α, in a patient with a paraganglioma and sickle cell diseaseKalyan Mansukhbhai Shekhda, Rishi Iyer, Mercedes Robledo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapyA Pollack, G K Zagars, C J Cole, et al.
Clinical Genetics|August 23, 2006
E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancerJ Lin, C P Dinney, H B Grossman, et al.
Radiology|April 6, 1999
Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modelingY Sugawara, K R Zasadny, H B Grossman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Linear growth and final height after treatment for Cushing's disease in childhoodM C Lebrethon, A B Grossman, F Afshar, et al.
The American Journal of Psychiatry|October 1, 1983
Different definitions of alcoholism, II: A pilot study of 10 definitions in a treatment settingJ H Boyd, K Derr, B Grossman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2009
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotidePhillip Kelly, Kathy T Maher, Shern L Chew, et al.
Folia Histochemica Et Cytobiologica|January 1, 1995
Non-isotopic procedure with silver staining of polyacrylamide gels in detection of genomic abnormalities in tumors using microsatellitesJ Podolski, P Hadaczek, Z Gibas, et al.
Pageof 80